| Application no. and date | 13710214.1 (espacenet) (Federated) (European Patent Register), 20130301 | | Patent/reg. no. and date | DK/EP 2822590, 20161026 | | Publication date | 20150114 | | Priority no. and date | US 201261607671 P, 20120307 | | EP pub. no. and date |
EP 2822590 20150114 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | P81604668DK00E | | Inventor | CORVARI, Vincent, John, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288, US,
WILLIAMS, Barbara, Ann, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288, US,
DONOVAN, Patrick, Daniel, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288, US,
MARKHAM, Aaron, Paul, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/24 (2006.01) | | Title | IL-17-ANTISTOFFORMULERING | | Int. application no. | US2013028516 | | Int. publication no. | WO2013134052 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
